Lobbying Filing Details

Total Spending

$1,310,000

Activities

5

Lobbyists

5

Gov't Entities

20

Filing Information
Filing UUID:
8101157a-4b0b-4dd6-b754-736dc8fcebde
Type:
Q1 - 1st Quarter - Report
Period:
2021 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2021 at 8:43 PM
Income:
$0
Expenses:
$1,310,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Elizabeth Hall
Registrant
ELEVANCE HEALTH, INC.

Health Benefits Company

Washington, District of Columbia
Client
ELEVANCE HEALTH, INC.
District of Columbia, United States of America
Lobbying Activities (5)
Activity 1
Financial Institutions/Investments/Securities

COBRA Subsidies
Federal Medical Assistance Percentages (FMAP) increase
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use, Parity and compliance issues;
Surprise medical billing;
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Medicare Sequestration, ACA subsidies, COVID vaccines and testing, COBRA subsidies, Consolidated Appropriations Act
Behavioral Health
Telehealth
Short Term Limited Duration health plans
Consolidated Appropriations Act, HR 133
Federal Medical Assistance Percentages (FMAP) increase

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107);
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues;
Surprise medical billing;
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
COVID-19 testing, vaccines, treatment, cost sharing
Federal Medical Assistance Percentages (FMAP) increase
Short Term Limited Duration health plans

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract consolidation, ESRD, audio-only telehealth
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicare Advantage Pilot Program in TRICARE
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Non Emergency Medical Transportation the Consolidated Appropriations Act (H.R. 133)
Maternal health (Medicaid postpartum coverage extension, H.R.959 Black Maternal Health Momnibus Act of 2021)

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)
Activity 5
Pharmacy

Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Drug Rebate Rule/Executive Order

Lobbyists (5)
  • ELIZABETH HALL
  • MR. SAMUEL JOHN MARCHIO
  • ADAM GOLDBERG
  • CATHERINE HANSEN NABAVI
  • JAMES STURSBERG
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.